NASDAQ:VRPX

Virpax Pharmaceuticals Stock Signals

etoro logo Buy VRPX
*Your capital is at risk
$0.0008
+0 (+0%)
At Close: Jun 22, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Virpax Pharmaceuticals, Inc.

General

Signal Type Signal Value Data
Score 0.000 105 days ( 92.73 %
Last Price $0.0008 0 %
Performance History
7 Days
$0.0008 $0.0008
0%
30 Days
$0.0005 $0.0008
60.00%
12 Mos
$0.250 $0.0008
-99.68%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 19.59
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0008 - $0.0008
Trend - 3 mos -48.60 % High Width: 223.92 %
Pred. range - 3 mos N/A - $0.0044 Low -100.00 % - 446.49 %
Volume Direction Sell High Volume: 33 · Direction: 0
Pivot Short Sell Very Low Jun 18, 2026 - 2 days
RSI Short Pivot Signal Buy Very Low Jun 11, 2026 - 7 days
Short MA 3 mos Buy Low Jun 03, 2026 - 13 days
Long MA 3 mos Sell Medium May 21, 2026 - 21 days
Short/Long MA 3 mos Sell Medium May 22, 2026 - 20 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.4
Signal Type Signal Value Importance Data
Trend - 12 mos -36.08 % Very High Width: 216.90 %
Pred. range - 12 mos N/A - $0.185 High -100.00 % - 22,969.98 %
Short MA 12 mos Buy Very High Apr 20, 2026 - 44 days
Long MA 12 mos Sell Very High May 21, 2026 - 21 days
Short/Long MA 12 mos Sell Very High May 26, 2026 - 19 days
Pivot Long Sell Low Jun 18, 2026 - 2 days
RSI Long Pivot Signal Buy Low Jun 11, 2026 - 7 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT VIRPAX PHARMACEUTICALS, INC.
Virpax Pharmaceuticals
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an inject...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE